Miricor Enterprises (HKG:1827) expects an estimated loss attributable to equity holders between HK$0.5 million and HK$1.5 million for the six months ended Sept. 30, narrower than HK$13.1 million logged for the same period last year, a Friday Hong Kong bourse filing said.
The medical aesthetic service provider attributed the decrease in loss to improved operational efficiency and cost control measures.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments